These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 29290100)

  • 21. The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.
    Brouwers B; Hatse S; Dal Lago L; Neven P; Vuylsteke P; Dalmasso B; Debrock G; Van Den Bulck H; Smeets A; Bechter O; Bailur JK; Kenis C; Laenen A; Schöffski P; Pawelec G; Journe F; Ghanem GE; Wildiers H
    Oncotarget; 2016 May; 7(21):29977-88. PubMed ID: 27102154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules.
    Muessel MJ; Klein RM; Wilson AM; Berman NE
    Brain Res Mol Brain Res; 2002 Jun; 103(1-2):12-27. PubMed ID: 12106688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
    Daly C; Rollins BJ
    Microcirculation; 2003 Jun; 10(3-4):247-57. PubMed ID: 12851642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic overexpression of C-C motif chemokine ligand 2 promotes metabolic dysregulation and premature death in mice with accelerated aging.
    Luciano-Mateo F; Cabré N; Baiges-Gaya G; Fernández-Arroyo S; Hernández-Aguilera A; Elisabet Rodríguez-Tomàs E; Arenas M; Camps J; Menéndez JA; Joven J
    Aging (Albany NY); 2020 Oct; 12(20):20001-20023. PubMed ID: 33104522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocyte chemoattractant protein 1 does not contribute to protective immunity against pneumococcal pneumonia.
    Dessing MC; de Vos AF; Florquin S; van der Poll T
    Infect Immun; 2006 Dec; 74(12):7021-3. PubMed ID: 16982835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
    Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
    Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monocyte chemoattractant protein-1 gene expression in injured pig artery coincides with early appearance of infiltrating monocyte/macrophages.
    Wysocki SJ; Zheng MH; Smith A; Lamawansa MD; Iacopetta BJ; Robertson TA; Papadimitriou JM; House AK; Norman PE
    J Cell Biochem; 1996 Sep; 62(3):303-13. PubMed ID: 8872602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocyte chemoattractant protein-1 (MCP-1): an overview.
    Deshmane SL; Kremlev S; Amini S; Sawaya BE
    J Interferon Cytokine Res; 2009 Jun; 29(6):313-26. PubMed ID: 19441883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catabolic Effects of Human PTH (1-34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism.
    Siddiqui JA; Johnson J; Le Henaff C; Bitel CL; Tamasi JA; Partridge NC
    Sci Rep; 2017 Nov; 7(1):15300. PubMed ID: 29127344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo properties of monocyte chemoattractant protein-1.
    Gu L; Rutledge B; Fiorillo J; Ernst C; Grewal I; Flavell R; Gladue R; Rollins B
    J Leukoc Biol; 1997 Nov; 62(5):577-80. PubMed ID: 9365111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte chemoattractant protein-1 in dogs affected with neoplasia or inflammation.
    Ishioka K; Suzuki Y; Tajima K; Ohtaki S; Miyabe M; Takasaki M; Mori A; Momota Y; Azakami D; Sako T
    J Vet Med Sci; 2013 Feb; 75(2):173-7. PubMed ID: 22986270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy.
    Kohl B; Fischer S; Groh J; Wessig C; Martini R
    Am J Pathol; 2010 Mar; 176(3):1390-9. PubMed ID: 20093502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction.
    Shahrara S; Pickens SR; Mandelin AM; Karpus WJ; Huang Q; Kolls JK; Pope RM
    J Immunol; 2010 Apr; 184(8):4479-87. PubMed ID: 20228199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin as a natural regulator of monocyte chemoattractant protein-1.
    Karimian MS; Pirro M; Majeed M; Sahebkar A
    Cytokine Growth Factor Rev; 2017 Feb; 33():55-63. PubMed ID: 27743775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B.
    Lynn EG; Siow YL; Frohlich J; Cheung GT; O K
    Kidney Int; 2001 Aug; 60(2):520-32. PubMed ID: 11473635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer.
    Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the
    Salah SM; Meisenheimer JD; Rao R; Peda JD; Wallace DP; Foster D; Li X; Li X; Zhou X; Vallejo JA; Wacker MJ; Fields TA; Swenson-Fields KI
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F343-F360. PubMed ID: 31091126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
    de Lemos JA; Morrow DA; Blazing MA; Jarolim P; Wiviott SD; Sabatine MS; Califf RM; Braunwald E
    J Am Coll Cardiol; 2007 Nov; 50(22):2117-24. PubMed ID: 18036447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels.
    Gonzalez E; Rovin BH; Sen L; Cooke G; Dhanda R; Mummidi S; Kulkarni H; Bamshad MJ; Telles V; Anderson SA; Walter EA; Stephan KT; Deucher M; Mangano A; Bologna R; Ahuja SS; Dolan MJ; Ahuja SK
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13795-800. PubMed ID: 12374865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
    Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
    Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.